Home
Technology Platforms
Harbour Mice
®
Single Cell Technology Platform
HBICE
®
Fully Human Generative AI HCAb Model
Therapeutics
Inflammatory & Immunology Diseases
Oncology/Immuno-Oncology
Weight Management
Publications
Harbour Medical
Overview
Clinical Development & Medical Services
Scientific Committee
IND-IIT Bidirectional Drive Model
AI-Empowered Full Clinical Trial Lifecycle
An Efficient and Collaborative Organizational System
Partnership
Technology Service
Technology License
Asset License
Co-development
Strategic Collaboration
Cooperation Contact
About Us
Company Overview
Corporate Strategy
Management Team
Scientific Advisory Board
Our History
Our Locations
Newsroom
Investor Relations
Corporate Governance
Stock Information
Disclosure
Financials
Presentations and Events
Analyst Coverage
Notices-Replacement of Lost Share Certificates
Subscribe to Updates
Careers
中国 — 简体中文
Global — English
Home
Technology Platforms
BACK
Technology Platforms
Harbour Mice
®
Single Cell Technology Platform
HBICE
®
Fully Human Generative AI HCAb Model
Therapeutics
BACK
Therapeutics
Inflammatory & Immunology Diseases
Oncology/Immuno-Oncology
Weight Management
Publications
Harbour Medical
BACK
Harbour Medical
Overview
Clinical Development & Medical Services
Scientific Committee
IND-IIT Bidirectional Drive Model
AI-Empowered Full Clinical Trial Lifecycle
An Efficient and Collaborative Organizational System
Partnership
BACK
Partnership
Technology Service
Technology License
Asset License
Co-development
Strategic Collaboration
Cooperation Contact
About Us
BACK
About Us
Company Overview
Corporate Strategy
Management Team
Scientific Advisory Board
Our History
Our Locations
Newsroom
Investor Relations
BACK
Investor Relations
Corporate Governance
Stock Information
Disclosure
Financials
Presentations and Events
Analyst Coverage
Notices-Replacement of Lost Share Certificates
Subscribe to Updates
Careers
Investor Relations
Effective Communication Drives Development
Corporate Governance
Stock Information
Disclosure
Financials
Presentations and Events
Analyst Coverage
Notices-Replacement of Lost Share Certificates
Subscribe to Updates
Home
>
Investor Relations
>
Disclosure
Disclosure
Listing Documents
Financial Report/ESG information
Announcement & Notice
IR Journal
2024-04-02
Next Day Disclosure Return
2024-03-28
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2023
2024-03-13
DATE OF BOARD MEETING
2024-03-07
Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2024
2024-02-27
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2024
2024-02-27
VOLUNTARY ANNOUNCEMENT - ENTERING INTO ANTIBODY-DRUG CONJUGATE DISCOVERY COLLABORATION AGREEMENT WITH BOOSTIMMUNE, INC.
2024-01-24
VOLUNTARY ANNOUNCEMENT FOOD AND DRUG ADMINISTRATION OF THE UNITED STATES IND CLEARANCE FOR HBM9027 CLINICAL TRIAL INITIATION
2024-01-19
POSITIVE PROFIT ALERT
2024-01-16
Dissemination of Corporate Communications
2024-01-12
GRANT OF SHARE OPTIONS AND GRANT OF SHARE AWARDS
2024-01-05
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2023
2023-12-20
Next Day Disclosure Return
2023-12-19
Next Day Disclosure Return
2023-12-15
INSIDE INFORMATION - ENTERING INTO LICENSE AGREEMENT WITH SEAGEN INC. FOR HBM9033
2023-12-06
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2023
2023-12-01
INSIDE INFORMATION - UPDATE ON THE DEVELOPMENT FOR BATOCLIMAB (HBM9161)
2023-11-03
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2023
2023-10-19
RESIGNATION OF JOINT COMPANY SECRETARY AND CHANGE OF AUTHORISED REPRESENTATIVE
2023-10-06
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2023
2023-09-06
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2023
1
···
12
13
···
21
Jump
